Chinese medicinal preparation for treating high blood pressure and high blood fat
A traditional Chinese medicine preparation, a technology for hyperlipidemia, which can be used in traditional Chinese medicine preparations with a therapeutic effect on hyperlipidemia and in the field of hypertension, and can solve problems such as serious side effects of western medicines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] Embodiment 1: the medicine of prescription: hawthorn 75g, astragalus 50g, cassia seed 75g, licorice 50g, kudingcha 50g, production process: according to conventional method, medicinal material and tealeaves are pulverized into coarse powder respectively, dry, mix evenly according to the prescription, divide and pack into drinking tea bags , packaged to get tea, the above dose can be bagged 100 packs, drink 2-4 packs a day. The product conforms to the relevant regulations under the first tea preparation of the "Chinese Pharmacopoeia" 2000 edition. This product is light brown yellow powder, sweet and slightly bitter. It has the functions of lowering blood fat and regulating blood pressure, and is used to treat and regulate hyperlipidemia and hypertension.
Embodiment 2
[0013] Embodiment 2: the traditional Chinese medicine Hawthorn 85g, Radix Astragali 50g, Semen Cassiae 85g, Radix Glycyrrhizae 40g, Kudingcha 40g, production process: according to conventional methods, medicinal materials and tea leaves are respectively pulverized into coarse powder, dried, mixed evenly according to the prescription, divided into drinking tea bags, Ready to pack, the above dosage can be made into 100 packs.
[0014] Clinical trial situation: systolic blood pressure (SBP) ≥ 21.3kPa (1kPa = 7.5mmHg) and (or) diastolic blood pressure (DBP) ≥ 12.6kPa is hypertension, cholesterol (TC) ≥ 5.72mmol / L, triglyceride (TG) ≥1.8mmol / L is hyperlipidemia. The comprehensive report of the situation of clinical treatment observation using this medicament is as follows:
[0015] 1 General Information:
[0016] Among the 100 cases in the test group, there were 36 males and 64 females; the age ranged from 30 to 74 years, with an average of (59.8±8.6) years; the course of disease...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More